Friday, November 03, 2017 10:15 PM ET
Insider Sale at Seattle Genetics (SGEN) Continues Selling Trend
An insider — Todd E Simpson, Officer — sold 39,385 shares of Seattle Genetics having a market value of approximately $2,398,915 today, as revealed in a form 4 document filed with the SEC. There have been 6 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 62,091 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 101,476 shares and have averaged 14,497 shares per transaction over this time period.
The number of insider buy/sell trades at Seattle Genetics is above that of the 185 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 211 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Seattle Genetics insiders is lower than its peers. Within the peer group there were 23,152,301 shares purchased and 51,386,307 shares sold with company insiders having sold 133,810 shares on average over this time period.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.